Silence Therapeutics (SLN) Revenue (2020 - 2026)
Silence Therapeutics recorded quarterly Revenue of $422000.0 in Q1 2026, up 1141.18% quarter-over-quarter from $34000.0 in Q4 2025, and up 197.18% year-over-year from $142000.0 in Q1 2025.
Silence Therapeutics' Revenue history runs 7 years deep, the most recent figure standing at $422000.0 for Q1 2026.
- In Q1 2026, Revenue rose 197.18% year-over-year to $422000.0; the TTM figure through Mar 2026 stood at $815000.0 (down 97.06% YoY), while the FY2025 annual figure was $559000.0, down 98.71% from the prior year.
- Revenue came in at $422000.0 for Q1 2026 at Silence Therapeutics, up from $34000.0 in the prior quarter.
- In the past five years, Revenue ranged from a high of $25.3 million in Q4 2024 to a low of $34000.0 in Q4 2025.
- A 5-year average of $5.7 million and a median of $3.5 million in 2023 frame the typical range for Revenue.
- Across the five-year window, Revenue surged 177002.77% in 2022 and tumbled 99.87% in 2025, its largest moves.
- Silence Therapeutics' Revenue stood at $5.6 million in 2022, then slumped by 53.39% to $2.6 million in 2023, then surged by 871.33% to $25.3 million in 2024, then sank by 99.87% to $34000.0 in 2025, then soared by 1141.18% to $422000.0 in 2026.
- According to Business Quant data, Revenue over the past three periods registered $422000.0, $34000.0, and $159000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 306.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 2.99 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 3.61 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.17 Bn |
| 10 | Silence Therapeutics | 924.61 Mn | 854.53 Mn | 411,000.00 | 422,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 422,000.00 |
| Dec 31, 2025 | 34,000.00 |
| Sep 30, 2025 | 159,000.00 |
| Jun 30, 2025 | 200,000.00 |
| Mar 31, 2025 | 142,000.00 |
| Dec 31, 2024 | 25.31 Mn |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 756,000.00 |
| Mar 31, 2024 | 15.70 Mn |
| Dec 31, 2023 | 2.61 Mn |
| Sep 30, 2023 | 3.54 Mn |
| Jun 30, 2023 | 11.39 Mn |
| Mar 31, 2023 | 13.83 Mn |
| Dec 31, 2022 | 5.59 Mn |
| Sep 30, 2022 | 3.97 Mn |
| Jun 30, 2022 | 4.59 Mn |
| Mar 31, 2022 | 7.68 Mn |
| Dec 31, 2021 | 4.60 Mn |
| Sep 30, 2021 | 4.35 Mn |
| Jun 30, 2021 | 3.78 Mn |
| Mar 31, 2021 | 4,335.33 |
| Dec 31, 2020 | 7.23 Mn |
| Sep 30, 2020 | 2,565.52 |